Focus: SpectronRx is a contract development and manufacturing organization (CDMO) specializing in diagnostics, radionuclides, and contract manufacturing with a focus on oncology applications. Based in Indianapolis, the company manufactures FDA-approved radiopharmaceutical diagnostics.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow SpectronRx to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Mature ANDA product generating cash flow from diagnostic imaging applications.
Help build intelligence for SpectronRx
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from SpectronRx's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Flagship PET diagnostic imaging agent with established market presence in oncology and neurology.
Established cardiac imaging diagnostic with stable demand in nuclear cardiology.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo